Harvard Dermatopathology Update 2024

Welcome and Introduction

Break

Predictive Dermatopathology: Toward more precise assessment of progression risk and therapeutic efficacy in human melanoma
George F. Murphy, MD

Break

Cutaneous T cell lymphoma (CTCL) and mimics
Lyn Duncan, MD

Break

Cutaneous B cell neoplasms
Judith Ferry, MD

Break

Cutaneous Fibrosing Disorders
Rosalynn Nazarian, MD

Break

An Approach to Quality and Safety in Dermatopathology: Quality Improvement and Workflow Redesign
Mia S. DeSimone, MD, MPH

Break

Expert Panel
Lyn Duncan, MD; Mai Hoang, MD; George F. Murphy, MD; Steven Tahan, MD; Julia Lehman, MD

Welcome

Break

New Insights into Lesions We Thought We Knew
Steven Tahan

 Break

Pediatric Dermatopathology
Birgitta Schmidt, MD

Break

New diagnostic criteria for oral leukoplakias
Sook-Bin Woo, DMD

Break

Practical pearls in autoimmune connective tissue diseases
Julia Lehman, MD

Break

Challenging cases of immunobullous diseases
Julia Lehman, MD

Break

Inflammatory Vulvar Lesions
Ashley Ward, MD

Break

HPV-Negative Squamous Vulvar Lesions
Jaclyn Watkins, MD

Welcome

Break

Updates in Adnexal Neoplasms
Eleanor Russell-Goldman, MD, PhD

Break

Cutaneous Mesenchymal Tumors: Morphology and Molecular Correlates
Ivan Chebib, MD

Break

Pearls and Pitfalls in the diagnosis of cutaneous mycobacterial infections
Alvaro Laga Canales, MD, MSc

Break

Practical approach to difficult melanocytic tumors
Christine G. Lian, MD

Break

Squamous Penile Lesions
Kristine Cornejo, MD

Break

Eye Pathology of Pigmented Lesions
Anna Stagner, MD

Break

ALK+ cutaneous neoplasms
Ruth Foreman, MD, PhD